Table 1.
Apoptosis | Necrosis | Paraptosis | |
---|---|---|---|
Morphology | |||
Nuclear fragmentation | + | − | − |
Chromatin condensation | + | − | ± |
Apoptotic bodies | + | − | − |
Cytoplasmic vacuolation | − | + | + |
Mitochondrial swelling | Sometimes | + | Late |
Genomic effect | |||
TUNEL | + | Usually − | − |
Internucleosomal DNA fragmentation | + | − | − |
Caspase activity | |||
DEVD-cleaving activity | + | − | − |
Caspase-3 processing | + | − | − |
PARP cleavage | + (85-kDa fragment) | + (50- to 62-kDa fragments) | − |
Inhibition by: | |||
zVAD.fmk | + | − | − |
BAF | + | − | − |
p35 | + | − | − |
xiap | + | − | − |
Bcl-xL | + | Usually − | − |
Actinomycin D | Sometimes | − | + |
Cycloheximide | Sometimes | − | + |
DEVD, Asp-Glu-Val-Asp; PARP, poly(ADP-ribose) polymerase.